SOURCE: RZN Nutraceuticals

February 12, 2007 06:00 ET

Clinical Trial Finds Herbal Supplement Effectively Relieves Arthritis Pain

100% of Subjects Pain-Free After Using Arthri-Zen Relief®, With No Adverse Effects

MIAMI, FL -- (MARKET WIRE) -- February 12, 2007 -- Seventy million Americans suffer from the debilitating effects of arthritis or chronic joint problems, per the CDC. And while pain-relieving pharmaceuticals abound, most have been discovered to have serious -- and sometimes deadly -- side effects. The good news is that it's possible to get safe, effective relief. A new randomized, placebo-controlled human clinical trial found that Arthri-Zen Relief®, an herbal supplement manufactured by RZN Nutraceuticals, completely relieved arthritis pain in 100% of subjects within 14 days -- without causing any side effects.

The Arthri-Zen Relief® formula was the subject of three clinical trials showing it to be effective at relieving the crippling pain of arthritis. The current 30-day trial, conducted by independent Fenestra Research Labs, was undertaken to validate the scientific research supporting the product. Seventy five subjects with extreme arthritis pain were recruited for the study. Fifty took Arthri-Zen Relief®; 25 took placebo.

The results were dramatic. Subjects taking placebo had no change in pain level during the study. By day 4, however, only 53.1 percent of those taking the Arthri-Zen Relief® were still at pain level 9-10. Three days later, that figure dropped to 6.1 percent, and by day 7, it was 0 percent. On the tenth day, 85.7 percent of patients were reporting no pain at all. And by day 14, every single one of the people in the test group was completely pain-free. No rescue medications were allowed over the course of the 30-day trial -- which means the effects were solely due to the Arthri-Zen Relief®.

Arthri-Zen Relief® is made from a proprietary blend of extracts of juniper, goldenrod, dandelion, meadowsweet and willow bark, conjugated to fruit sugars and polysaccharides in a patent-pending delivery system that ensures their absorption. It relieves arthritis pain in three specific ways: first, by blocking the transmission of pain signals; second, by reducing swelling in the joints; and third, by decreasing inflammation in the affected tissues.

RZN Nutraceutical founder and Chief Scientist Mark Lubin is a biomedical engineer who has 12 U.S. patents issued or pending for biomedical and technical innovations.

For more information on Migra-Zen Relief Plus® or the three Arthri-Zen Relief® formulations, visit www.rznnutra.com or call Robert Hunt 904-276-8324.

Contact Information

  • Media contact:
    Christie Communications
    805-969-3744